Home28L • FRA
add
Peptonic Medical AB
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 2.58M | -53.31% |
Operating expense | 10.64M | -22.04% |
Net income | -11.24M | -0.95% |
Net profit margin | -435.50 | -116.23% |
Earnings per share | — | — |
EBITDA | -9.01M | 7.71% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 908.00K | -88.93% |
Total assets | 68.00M | -23.94% |
Total liabilities | 29.18M | 88.26% |
Total equity | 38.83M | — |
Shares outstanding | 9.34B | — |
Price to book | ∞ | — |
Return on assets | -33.03% | — |
Return on capital | -40.39% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -11.24M | -0.95% |
Cash from operations | -7.43M | 63.10% |
Cash from investing | 217.00K | 110.92% |
Cash from financing | 3.14M | -88.97% |
Net change in cash | -4.76M | -174.67% |
Free cash flow | -3.01M | -120.27% |
About
Founded
2009
Website
Employees
3
